Previous close | 11.67 |
Open | 7.30 |
Bid | 5.00 |
Ask | 8.20 |
Strike | 60.00 |
Expiry date | 2024-06-21 |
Day's range | 7.30 - 7.30 |
Contract range | N/A |
Volume | |
Open interest | 2.84k |
Fady Malik, Executive Vice President of Research & Development at Cytokinetics Inc (NASDAQ:CYTK), sold 7,788 shares of the company on June 11, 2024.
On June 10, 2024, Muna Bhanji, a Director at Cytokinetics Inc (NASDAQ:CYTK), sold 2,000 shares of the company at a price of $52.07 per share.
On June 3, 2024, B Parshall, Director at Cytokinetics Inc (NASDAQ:CYTK), executed a sale of 5,000 shares of the company.